Micropore drainage to prevent hematoma in axillary bromhidrosis: A comparative study

微孔引流预防腋窝臭汗症血肿:一项比较研究

阅读:2

Abstract

Axillary bromhidrosis is characterized by malodor stemming from hyperplastic and hypertrophic apocrine sweat glands. Although surgical excision remains the most definitive treatment, postoperative complications-particularly hematoma-can compromise outcomes and patient satisfaction. This study evaluated the effectiveness of a micropore drainage technique in reducing hematoma and improving overall results. This retrospective comparative study analyzed data from medical records of 73 patients diagnosed with axillary bromhidrosis who underwent surgical treatment at the 3201 Hospital in Hanzhong, China, from January 2020 to January 2024. Patients had initially been randomized into either the experimental group (group A, n = 38), which received micropore drainage combined with subdermal undermining via a miniature incision, or the control group (group B, n = 35), treated by subdermal undermining alone. Inclusion and exclusion criteria were strictly followed during retrospective selection. Outcomes, evaluated by blinded assessors, included malodor elimination, Dermatology Life Quality Index (DLQI) scores, hair growth reduction, scar formation, postoperative complications, and patient satisfaction. Both groups achieved significant improvements in malodor control and DLQI scores. Notably, the hematoma rate was 0% in Group A compared to 11.43% in Group B (P = .02). Group A also demonstrated higher patient satisfaction (81.58% vs 51.43%, P = .01). There were no significant differences between the groups in operative time, scar formation, DLQI improvement, or hair growth reduction. Incorporating micropore drainage into surgical management of axillary bromhidrosis effectively reduces postoperative hematoma and enhances patient satisfaction without increasing operative complexity or compromising apocrine gland removal. This technique shows promise as a safer, more reliable option for axillary bromhidrosis treatment, warranting further validation through larger multicenter studies and longer-term follow-up.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。